SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial.

about

SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial.

Item

http://www.wikidata.org/entity/Q52609425

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

SPIRE - combining SGI-110 with ...... IIa open label clinical trial.

@en

SPIRE - combining SGI-110 with ...... IIa open label clinical trial.

@nl

type

Item

label

SPIRE - combining SGI-110 with ...... IIa open label clinical trial.

@en

SPIRE - combining SGI-110 with ...... IIa open label clinical trial.

@nl

prefLabel

SPIRE - combining SGI-110 with ...... IIa open label clinical trial.

@en

SPIRE - combining SGI-110 with ...... IIa open label clinical trial.

@nl

P1476

SPIRE - combining SGI-110 with ...... IIa open label clinical trial

@en

P2093

Amy Whitehead

http://www.w3.org/2001/XMLSchema#string

Cathy McDowell

http://www.w3.org/2001/XMLSchema#string

David Hathorn

http://www.w3.org/2001/XMLSchema#string

Deborah Ellis

http://www.w3.org/2001/XMLSchema#string

Denise Dunkley

http://www.w3.org/2001/XMLSchema#string

Gareth Griffiths

http://www.w3.org/2001/XMLSchema#string

James N Lowder

http://www.w3.org/2001/XMLSchema#string

Jessica Rajaram

http://www.w3.org/2001/XMLSchema#string

Joshua Caddy

http://www.w3.org/2001/XMLSchema#string

Mihalis Kalevras

http://www.w3.org/2001/XMLSchema#string

P2860

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study

LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors.

Integrated epigenome profiling of repressive histone modifications, DNA methylation and gene expression in normal and malignant urothelial cells.

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1.

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines.

Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer.

P2888

s13063-018-2586-7

P304

216

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13063-018-2586-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Simon J Crabb

James Catto

P577

2018-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103148487

http://www.w3.org/2001/XMLSchema#string

P698

29615077

http://www.w3.org/2001/XMLSchema#string

P932

5883402

http://www.w3.org/2001/XMLSchema#string